- Dosage: Diphenhydramine 100mg
- Volume: 2 ml Ampoule
- Packaging: 2 ml ampoule * 10/tray/box*300 carton
- Shelf Life: 36 months
Package:
Product Description
Product Overview
Diphenhydramine Injection 50mg/mL is a sterile, aqueous solution of diphenhydramine hydrochloride intended for parenteral administration. Each 2mL ampoule contains 100mg of diphenhydramine hydrochloride at a concentration of 50mg/mL. Diphenhydramine is a first-generation H1 antihistamine belonging to the ethanolamine chemical class, with a broad pharmacological profile including antihistaminic, sedative, antiemetic, and anticholinergic activities.
Diphenhydramine Injection 50mg/mL 2mL: What the Published Guidance Says
The resuscitation, antidote and critical-care injectables that a functioning emergency department cannot run without — most of them named directly on the WHO Model List.
Diphenhydramine Injection 50mg/mL 2mL is specified against its own monograph, pack size and market registration, so the guidance below is worth reading together with the Emergency & Critical Care range overview.
- Anaphylaxis and acute allergy The Model List places epinephrine (adrenaline) among the medicines used in anaphylaxis, and carries dexamethasone injection 4 mg/mL in 1 mL ampoule as disodium phosphate salt for both antiallergic use and palliative care, as well as in the antiemetic section. WHO Model List of Essential Medicines, 24th List (2025) — report of the 25th WHO Expert Committee (TRS 1064)
- Pre-operative and emergency antimuscarinics Atropine appears twice on the Model List — as a pre-operative medication at 400 micrograms/mL and 1 mg/mL (sulfate) in 1 mL ampoule or vial, and among specific antidotes. WHO Model List of Essential Medicines, 24th List (2025) — report of the 25th WHO Expert Committee (TRS 1064)
- Dexamethasone is a multi-role hospital injectable Beyond allergy, the Model List carries dexamethasone injection in the antiemetic section, where it appears alongside metoclopramide and ondansetron. WHO Model List of Essential Medicines, 24th List (2025) — report of the 25th WHO Expert Committee (TRS 1064)
We quote these sources rather than paraphrase them loosely, because the detail matters commercially for Diphenhydramine Injection 50mg/mL 2mL. Where your national list differs from the WHO listing, the national list governs what may be supplied and promoted locally.
Supply & Specification Data for Diphenhydramine Injection 50mg/mL 2mL
| Product Name | Diphenhydramine Injection |
| Specification | 50mg/mL, 2mL ampoule (100mg total per ampoule) |
| Dosage Form | Sterile Solution for Injection |
| Active Ingredient | Diphenhydramine Hydrochloride |
| Pharmacological Class | First-Generation H1 Antihistamine (Ethanolamine Class) |
| Route of Administration | Intravenous injection (slow), or deep intramuscular injection |
| Storage | Store below 25°C, protected from light. Do not freeze. Keep ampoule in outer carton until use. |
| Therapeutic group | Emergency & Critical Care — Emergency & Critical Care |
| Manufacturer | Sinophare Bio-technology Co., Ltd. (GMP, China) |
| Documentation supplied | COA, HPLC/GC data, stability data, dossier package |
The same therapeutic range is supplied in several presentations, so one purchase order can cover a mixed requirement: Nimodipine Injection 10mg/50ml, Heparin Sodium Injection 2mL:5000IU, Citicoline Injection 2ml:250mg Ampoule, Aceglutamide Injection 100mg/5mL, Dobutamine Injection 12.5mg/mL 2mL, Dexamethasone Injection 8mg/2mL, Acetylcysteine Injection 1g/5mL, Phentolamine Injection 10mg/1mL.
Testing, Monographs & Batch Documentation
Products are manufactured and tested against USP, EP, BP and CP monographs, with incoming raw-material inspection, in-process monitoring and full finished-product testing.
Every batch of Diphenhydramine Injection 50mg/mL 2mL is tested to the monograph stated on the purchase order. Where a monograph is silent on the presentation, we agree a written specification with you in advance and reference it on the certificate of analysis.
Standardised GMP production workshops with an independent R&D laboratory and a complete quality-inspection centre.
The batch record for this product normally includes:
- Testing for water content and pH where applicable
- Testing for sterility and bacterial endotoxins (parenterals and ophthalmics)
- Testing for microbial limits and preservative efficacy (multi-dose presentations)
- Testing for heavy metals and elemental impurities
- Testing for packaging integrity and seal testing
- Testing for description and identification
COA, HPLC and GC data, DMF and dossier packages, plus registration support documents for national marketing-authorisation filings.
Pack Configuration, Artwork & Shipping Documents
- Pack size: 2mL amber glass ampoule. Non-standard pack sizes can be quoted against your artwork.
- Storage: Store below 25°C, protected from light. Do not freeze. Keep ampoule in outer carton until use..
- Shelf life: 36 months (unopened). Stability data for the marketed pack is included in the dossier.
- Labelling: we typeset the carton and leaflet in English, Arabic, French, Russian and Spanish and in any further language your market requires, carrying your own brand where the local rules allow.
- Export: commercial invoice, packing list, certificate of origin, GMP certificate, COA and the free-sale certificate issued by the country of manufacture whenever your customs or regulator asks for it.
Dossier, Authority Filings & Tender Documentation
Documents for Diphenhydramine Injection 50mg/mL 2mL are issued by Sinophare Bio-technology Co., Ltd. — DML Number Jin20160068 (medicines) and Jin20160069 (paracetamol API).. Keeping one legal manufacturer across the COA, the GMP certificate and the registration file avoids assessment queries later.
- Artwork and mock-up approval pack, showing the carton, label and leaflet exactly as they will be printed for your market.
- Batch manufacturing and packaging records released for inspection on request during supplier audits.
- Re-test or renewal support when the marketing authorisation comes up for variation or renewal.
- CTD dossier modules 1–5 in editable and PDF form, with the finished-product and API sections cross-referenced.
- Site Master File and GMP certificate for the manufacturing workshops.
The context for Diphenhydramine Injection 50mg/mL 2mL is its place among emergency and critical-care injectables named in the WHO Model List. Listing status informs how programmes specify a product; it is not a substitute for the import licence or marketing authorisation of the destination country.
Buyer Questions about Diphenhydramine Injection 50mg/mL 2mL
What pack size is available for Diphenhydramine Injection 50mg/mL 2mL?
This presentation is normally supplied as 2mL amber glass ampoule. Where your market requires a different count, bottle or carton, we quote to your artwork and extend the stability file to the new pack.
What documentation comes with a shipment of Diphenhydramine Injection 50mg/mL 2mL?
Shipments are accompanied by a certificate of analysis covering identification, assay and related substances, together with the marketed-pack stability data and the manufacturing site GMP certificate. Shelf life: 36 months.
Does the batch documentation for Diphenhydramine Injection 50mg/mL 2mL support a registration filing?
Shipments are accompanied by a certificate of analysis covering identification, assay and related substances, together with the marketed-pack stability data and the manufacturing site GMP certificate. Shelf life: 36 months. The full CTD dossier and the authority assessment file are supplied as part of a registration order; routine shipments carry the COA and stability data only.
Do you supply acetylcysteine as the paracetamol antidote?
Yes. Acetylcysteine injection is available for paracetamol overdose management; the Model List names acetylcysteine among specific antidotes.
Can you supply calcium gluconate for magnesium sulfate overdose?
Yes. Calcium gluconate injection is supplied both as an electrolyte replacement and as the antidote used when magnesium sulfate toxicity occurs.
Other Emergency & Critical Care Products in This Range
- Nimodipine Injection 10mg/50ml — 10mg
- Heparin Sodium Injection 2mL:5000IU — 5000IU
- Citicoline Injection 2ml:250mg Ampoule — 250mg/2mL
- Aceglutamide Injection 100mg/5mL — 100mg/5mL
- Dobutamine Injection 12.5mg/mL 2mL — 12.5mg/mL
- Dexamethasone Injection 8mg/2mL — 8mg/2mL
Browse the full Emergency & Critical Care range; all Injectables; the complete product catalogue.
Request a Quotation for Diphenhydramine Injection 50mg/mL 2mL
For tenders and programme supply, send the line item, pack size, quantity and destination for Diphenhydramine Injection 50mg/mL 2mL 50mg/mL. We return a quotation with lead time, documentation list and sample availability in one response.
Sources & Regulatory Notes
Reference information only. The published guidance summarised on this page is quoted for professional and regulatory-context purposes and does not constitute medical advice, a prescribing recommendation or a promotion of any product for a particular indication. Prescribing decisions must follow the approved product information and national treatment guidelines in the market of use.
